Hope to Prevent Diseases and the Responsibility to Rewrite the Future - If It's Banned in Japan, What About Overseas? Genome Editing Challenges the "Rights of Future Children"

Who Decides "Pre-Birth Genes"? The Question Posed by Japan's New Law to the World

The desire not to pass on severe illnesses to children is understandable to many.

But is it acceptable to alter the genetic information of embryos for this purpose? If the changes could affect not only the child to be born but also future generations, who should make the decision, and who will bear the responsibility?

The debate over genome editing is challenging because the hope for medical advancements and the concerns over irreversible impacts coexist.

On October 28, 2026, the science news site Phys.org featured an essay by Professor Tsutomu Sawai of Hiroshima University on Japan's new legal framework. The focus is on a law regulating the handling of human genome-edited embryos and reproductive cells.

Japan's step forward is not merely a halt on technology. It is an attempt to demonstrate how to protect the safety of future individuals while advancing research, along with legal responsibility.

From "Prohibited" to "Regulated with Penalties"

The "Act on Regulation of Handling of Human Genome-Edited Embryos, etc." was enacted on July 17, 2026, and promulgated on July 24 of the same year. The enforcement date is set for July 24, 2027. Thus, as of October 2026, the law has been enacted, but the main regulations are yet to be enforced.shugiin.go.jp

This time lag is important to note when reading the news. "The law has been created" and "the regulations are already in effect" are not the same.

According to the original article, Japan had not previously allowed the reproductive use of genome-edited human embryos. However, there was a legal gap in directly penalizing their implantation. This legislation transforms such guideline-based regulations into a system with penalties.

The law's scope is not limited to the moment of implantation. It also regulates creation, acquisition, import, and use, requiring the submission of handling plans and adherence to guidelines. The system includes administrative measures such as reporting requirements, on-site inspections, and improvement orders.mhlw.go.jp

The significance of this legal framework lies in creating a system where organizations can verify and, if necessary, halt actions, rather than relying solely on the caution of individual researchers.

Genome Editing in Medicine Is Not Entirely Prohibited

Hearing "a law regulating genome editing" might give the impression that the development of new treatments is halted. However, it is essential to consider two different applications separately.

One is genome editing targeting the patient's own body cells. Changes are made to cells to treat diseases, with the effects primarily confined to the individual receiving treatment.

The other involves altering embryos or reproductive cells for use in pregnancy and childbirth. In this case, the changes could be passed on to the next generation.

The original article emphasizes that the new law distinguishes between these differences. It does not uniformly prohibit somatic cell genome editing treatments targeting the patient. It also leaves room for basic research using human embryos under legal supervision.

Therefore, understanding it as a binary choice between "advancing treatment" or "ensuring safety" misses the law's intent.

Which cells are targeted? Is it at the research stage or intended for pregnancy? Who will be affected? Even with the same term "genome editing," the necessary judgments vary depending on these differences.

Future Children Cannot Refuse Participation in Research

In genome editing leading to reproduction, the individuals who bear the benefits and risks cannot participate in the decision-making beforehand.

Of course, parents routinely make choices affecting their children's future, such as where to live, education, and healthcare, even when the children cannot decide for themselves. It is not possible to deny all choices simply because "there is no consent from the individual."

Still, intervening in genetic information has its unique challenges.

The effects of changes need to be confirmed over a long period, and there is also the possibility of passing them on to the next generation. Finding no problems immediately after birth is not the same as confirming lifelong safety.

The essay introduced in the original article also emphasizes the importance of verifying long-term effects across multiple generations and the issue of future children's consent.

What is needed here is not to dismiss parental wishes as unimportant. It is to respect those wishes while maintaining a perspective that examines the benefits for the individuals to be born, separate from those who wish for them.

Domestic Prohibition Alone Cannot Address Cross-Border Actions

Another challenge pointed out by Professor Sawai is the limitation of domestic law.

Even if one country establishes strict regulations, there remains the possibility that individuals will seek to carry out such practices in other countries with weaker regulations and oversight. In such cases, merely prohibiting it domestically does not eliminate the problem itself.

However, this does not mean that "it can be safely received abroad" or "there are legal providers overseas." The point is that differences in national systems can motivate people to circumvent regulations.

The World Health Organization (WHO), in its 2021 recommendations on genome editing, also addressed international cooperation, research registration, international research and medical travel, and responses to illegal, unregistered, unethical, and dangerous research.who.int

From this perspective, what is needed is not just for each country to display the same prohibition wording. It is crucial to share information on problematic research and provision activities and to create a system where research institutions and medical facilities can verify with common standards.

Creating laws is a starting point, and collaboration with areas beyond the reach of those laws also influences the effectiveness of the system.

On Social Media, "Hope to Prevent Disease" and "Fear of Imposing Risks" Intersect

Public interest in this issue extends beyond expert discussions.

On the overseas forum Reddit, multiple opinions were posted following reports on Japan's bill on April 10, 2026. The following is a summary of prior discussions on the same regulation, not direct reactions to the October 28 Phys.org article. Additionally, it is not possible to determine the overall public opinion from a limited number of posts.

One prominent point of discussion is whether the use for altering appearance or abilities should be separated from the use for preventing hereditary diseases.

Posts expressed doubts about restricting editing to avoid health issues and expectations for researching the potential to reduce diseases. On the other hand, concerns were raised about unintended changes and the limitations in understanding gene functions, fearing the imposition of risks on children.

Furthermore, there are concerns that if such technologies become available in the future, only those who are economically privileged may have access, potentially deepening disparities.reddit.com

Common to these opinions is the question, "What is the purpose of the technology?"

Is it to reduce suffering from diseases? Is it to select traits desired by parents? Will it become a system where only those who can access it benefit? Discussing only the performance of the technology will not lead to an answer.

The Difference Between "Testing" and "Editing" Not to Be Overlooked on Social Media

In the same Reddit discussion, a poster who mentioned having a hereditary disease shared their experience of being unable to receive desired reproductive medical care in Japan.

However, upon reading the exchange, it becomes clear that what the person specifically referred to was preimplantation genetic testing for monogenic disorders, "PGT-M." This post cannot be introduced as an experience of a patient denied genome editing.reddit.com

Testing and editing are separate actions. If genetic information examination and genetic information modification are treated together, it becomes unclear what is restricted and what is being discussed.

On the other hand, merely pointing out this confusion does not fully acknowledge the earnestness expressed in the post.

For individuals and families with hereditary diseases, this is not a distant future technology debate. It is a matter concerning their current lives, such as whether to have children and what options are available.

Those explaining the system are required to both accurately distinguish the technology and respect the distress of those involved.

Not Confusing "Reducing Diseases" with "Choosing Human Worth"

In discussions about genome editing, there is a danger that the expectation for disease prevention and treatment might inadvertently shift to discussions about "what kind of people should be born."

Aiming for medical care that reduces suffering and undervaluing the lives of people with illnesses or disabilities are entirely different matters.

Moreover, if a choice becomes technically feasible, it does not necessarily mean that freedom increases. There is also the possibility of pressure being directed at parents and families with the question, "Why didn't you use it when it was available?"

This is not something that can be definitively stated as bound to happen with the introduction of technology. However, it is a social issue that should be considered at the stage of designing the system.

To deepen the discussion in Japan, the experiences of patients, people with disabilities, families, and those involved in reproductive medicine are indispensable, alongside researchers and legal experts. In addition to evaluating safety, attention should also be given to what kind of expectations and pressures the technology will generate in society.

Future Revisions Should Not Be a Reason to Take Current Regulations Lightly

The essay introduced in the original article also states that the current prohibition does not necessarily mean a permanent ban in the future. There is room to reconsider regulations as scientific knowledge, safety, and ethical understanding progress.

However, "the possibility of future revision" and "it is okay to proceed now" are different.

Future discussions will not only question how precise the technology has become. Is there a necessity that cannot be addressed by other means? How will long-term impacts be confirmed? Who will the benefits and burdens be distributed to? How will the rights of those to be born be protected?

There are issues to consider in both fixing regulations and easing them lightly. Therefore, it is necessary to make the discussion of revisions itself public and ensure diverse positions can participate.

Connecting Japan's Step to a System Protecting Future Generations

The significance of this legal framework lies in demonstrating that a society advancing scientific technology also takes responsibility for its use.

However, establishing penalties does not resolve ethical issues. Challenges remain, such as avoiding overseas regulation circumvention, providing information to patients and families, ensuring research transparency, and addressing disparities in access to the benefits of technology.

While we hope for the potential to reduce the suffering of diseases, we also do not want to impose unverified risks on children. These two feelings are not necessarily contradictory.

The question posed by Japan's new law is not just whether genomes can be rewritten. It is about who and how the interests of those who cannot yet voice their concerns will be protected when using that power.

Sources and References

1. Phys.org / Article provided by Hiroshima University (October 28, 2026)
   Introducing Professor Tsutomu Sawai's evaluation of Japan's legal framework, the distinction from somatic cell treatment, and the need for international cooperation.
   https://phys.org/news/2026-10-japan-genome-law-global-ethics.html

2. Nature Medicine: Tsutomu Sawai "A binding ban, and its limits: Japan legislates on heritable human genome editing"
   The essay introduced in the original article discusses the significance of Japan's regulation with penalties and the limitation of cross-border regulation circumvention.
   https://www.nature.com/articles/s41591-026-04641-x

3. Ministry of Health, Labour and Welfare "On the Regulation of Handling Human Genome-Edited Embryos, etc."
   Confirmation materials on the law's scope, the principle prohibition of implantation, supervisory measures regarding research handling, and the enforcement date.
   https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/iryou/saisei_iryou/index_00019.html

4. House of Representatives "Deliberation Process of the Bill on Regulation of Handling Human Genome-Edited Embryos, etc."
   Confirmation materials on the enactment on July 17, 2026, and promulgation on July 24 of the same year.
   https://www.shugiin.go.jp/Internet/itdb_gian.nsf/html/gian/keika/1DE279E.htm

5. WHO "Human genome editing: recommendations" (2021)
   Recommendations on international cooperation, research registration, medical travel, and responses to dangerous and unethical research.
   https://www.who.int/publications/i/item/9789240030381

6. Reddit / r/technology (Posts regarding related reports on April 10, 2026)
   A public thread confirming expectations for disease prevention, concerns about safety and disparities, and experiences related to PGT-M. These are individual posts and not medical evidence or public opinion surveys.
   https://www.reddit.com/r/technology/comments/1shg3lh/japan_to_ban_geneedited_embryos_aimed_at_creating/